// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Diabetes Mellitus and Blood Glucose Variability Increases the 30-day Readmission Rate After Kidney Transplantation

H. Chakkera - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Direct Procurement of Heart and Lungs from a Controlled DCD Donor with Ongoing Abdominal Normothermic Regional Perfusion (aNRP) – A Synchronized Retrieval

M. Husain - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Domino Living Donor Kidney Transplant Following Therapeutic Nephrectomy for Renal Artery Stenosis with Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series

R. Pearson - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal artery stenosis

N/A

Donor Factors Do Not Discriminate Living Donor Kidney Transplant Outcomes and Should Not Be Used to Promote the Use of Compatible Pairs in Kidney Paired Donation Programs

G. Irish - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

En-Bloc Kidney Transplantation in Children Over a 33-year Period in USA – A Comparative Study

P. Gogalniceanu - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluating the Performance and External Validity of Machine Learning-Based Prediction Models in Liver Transplantation: An International Study

T. Ivanics - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

HLA-DQ Mismatches Are More Likely to Be Listed as Unacceptable Antigens After Renal Graft Failure in African American Recipients as Compared to Other Racial/Ethnic Groups

D. Isaacson - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identification of Soluble and Cellular Biomarkers in Blood of End-Stage Patients Before Pediatric Liver Transplantation (pLTx)

E. Chichelnitskiy - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implementation of Robotic Approach for Living Donor Nephrectomy in a High-Volume Laparoscopic Centre

G. Papadakis - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Kidney Transplantation from Deceased Donors with Vaccine-Induced Thrombosis and Thrombocytopenia: An Updated Analysis of the UK Experience

G. Greenhall - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Thrombocytopenia

N/A

Less is More. Extensive Cardiac Investigations Add Little Value in Waitlisting Patients for Kidney Transplantation

B. Chow - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Transient Ischemic Attack

N/A

Longitudinal Analysis of the Gut Microbiota Structure and Function After Renal Transplantation

A. Vaitkute - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Meta-Analysis of the Chronic Exposure to Calcineurin Inhibitors and the Risk for Chronic and End-Stage Kidney Disease in Non-Renal Solid Organ Transplant Recipients

A. Alvarez Elias - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Microvascular complications of diabetes 1

Cyclosporine eent

Metabolic Outcomes After Pancreas Transplant Alone from Donation After Circulatory Death Donor – The UK Registry Analysis

J. Gopal - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Metabolic Outcomes After Simultaneous Pancreas Kidney Transplant from Donation After Circulatory Death Donors – The UK Registry Analysis

J. Gopal - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Molecular Characterization of the Plasma Secretome in Pediatric Liver Transplantation (pLTx) Identified Cytokine/Chemokine Signatures Potentially Linked to Beneficial Immunosuppressive Regimes (IS) and Recovery

E. Chichelnitskiy - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Murine Intrahepatic Regulatory T Cells (TREGS) Modulate Acute Liver Inflammation by Promoting a Protective and Restorative Microenvironment

A. S. Kurt - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Normothermic Machine Perfusion (NMP) Improves Access to Transplantation for Late Liver Re-Transplant Candidates

D. Sneiders - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Normothermic Machine Perfusion of the Liver Supports Protein Translation and Mitochondrial Function While Reducing Protein Degradation and Metabolic Imbalance: A Proteomics Study

L. Lo Faro - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes of Transplants in Kidneys with Multiple Arteries

C. Seet - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved